Cargando…
Newer molecules in the treatment of schizophrenia: A clinical update
Schizophrenia is a heterogeneous psychiatric disorder in which multiple neurotransmitter systems have been implicated. Increased and decreased dopamine transmission in the subcortical meso-limbic and meso-cortical systems is closely linked to the “positive” and “negative” symptoms of schizophrenia,...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081445/ https://www.ncbi.nlm.nih.gov/pubmed/21572641 http://dx.doi.org/10.4103/0253-7613.77334 |